http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
김민중 ( Min Joong Kim ),김정희 ( Jung Hee Kim ),이은주 ( Eun Ju Lee ),유박린 ( Bark Lynn Lew ),심우영 ( Woo Young Sim ) 대한피부과학회 2013 대한피부과학회지 Vol.51 No.1
Epidermal growth factor receptor inhibitors (EGFRIs) are new anticancer agents that act by inhibiting EGFR signaling transduction pathways, thus decreasing tumor growth. They have made anti-cancer treatment more tolerable and have also reduced systemic side effects. However, they have many cutaneous side effects. Alopecia is an uncommon cutaneous side effect of EGFRIs, and cicatricial alopecia has been reported more rarely. A 59-year-old woman presented with itching and hair loss on the scalp, which started 2 months ago. She had been taking gefitinib for 7 months. A physical examination revealed localized erythematous hairless patches with scattered thick crusts on the scalp. Histopathologic examination showed a decreased number of hair follicles with perifollicular lymphocytes infiltration and perifollicular fibrosis, consistent with a scarring alopecia. We report a rare and interesting case of cicatricial alopecia after using the EGFRI, gefitinib. (Korean J Dermatol 2013;51(1):45∼48)
김민중,Kim, Min-Jung 대한에이즈예방협회 2006 레드리본 Vol.72 No.-
현재 국내에서는 법률상 남성과 여성의 구분, 즉 성을 어떤 기준에 따라서 결정하는가에 관한 별도의 규정을 두고 있지 않다. 그러나 현행 법계는 모든 사람이 남성 혹은 여성의 어느 하나에 포함된다는 사실을 전제로 하고 있다.